Indenix Pharmaceuticals Inc. (IDIX) Continues to Move Along at a Solid and Steady Pace
Indenix Pharmaceuticals Inc., a biopharmaceutical company, works to develop, test and market products directed primarily at infectious and viral diseases in the United States and Europe. The company has been having solid successes with a full pipeline of products. Although the company focuses a majority of its efforts on hepatitis C targeted products, it does have a rather interesting pipeline of products in development. This pipeline ranges from fully licensed hepatitis b products (to Novartis Pharma AG) and human immunodeficiency products (to GlaxoSmithKline), to Protease Inhibitors which are currently in the discovery stage. From an overall perspective, the company does…